US Bancorp’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $947K | Buy |
5,986
+2,798
| +88% | +$378K | ﹤0.01% | 1224 |
|
|
2026
Q1 | $407K | Sell |
3,188
-1,195
| -27% | -$149K | ﹤0.01% | 1615 |
|
|
2025
Q4 | $534K | Sell |
4,383
-382
| -8% | -$43.8K | ﹤0.01% | 1497 |
|
|
2025
Q3 | $477K | Sell |
4,765
-177
| -4% | -$15.9K | ﹤0.01% | 1533 |
|
|
2025
Q2 | $410K | Sell |
4,942
-577
| -10% | -$46K | ﹤0.01% | 1612 |
|
|
2025
Q1 | $448K | Sell |
5,519
-461
| -8% | -$41.2K | ﹤0.01% | 1542 |
|
|
2024
Q4 | $539K | Sell |
5,980
-190
| -3% | -$18.4K | ﹤0.01% | 1460 |
|
|
2024
Q3 | $610K | Sell |
6,170
-11,389
| -65% | -$1.12M | ﹤0.01% | 1395 |
|
|
2024
Q2 | $1.63M | Sell |
17,559
-343
| -2% | -$30.8K | ﹤0.01% | 916 |
|
|
2024
Q1 | $1.7M | Sell |
17,902
-323
| -2% | -$30K | ﹤0.01% | 902 |
|
|
2023
Q4 | $1.63M | Sell |
18,225
-4,111
| -18% | -$305K | ﹤0.01% | 904 |
|
|
2023
Q3 | $1.63M | Buy |
22,336
+1,883
| +9% | +$150K | ﹤0.01% | 875 |
|
|
2023
Q2 | $1.7M | Sell |
20,453
-3,057
| -13% | -$256K | ﹤0.01% | 850 |
|
|
2023
Q1 | $1.79M | Sell |
23,510
-7,416
| -24% | -$615K | ﹤0.01% | 844 |
|
|
2022
Q4 | $2.57M | Sell |
30,926
-284
| -0.9% | -$23K | ﹤0.01% | 729 |
|
|
2022
Q3 | $2.48M | Buy |
31,210
+10,539
| +51% | +$889K | 0.01% | 696 |
|
|
2022
Q2 | $1.53M | Buy |
20,671
+1,515
| +8% | +$114K | ﹤0.01% | 916 |
|
|
2022
Q1 | $1.72M | Buy |
19,156
+15,536
| +429% | +$1.43M | ﹤0.01% | 944 |
|
|
2021
Q4 | $405K | Sell |
3,620
-676
| -16% | -$81.5K | ﹤0.01% | 1635 |
|
|
2021
Q3 | $540K | Sell |
4,296
-10,542
| -71% | -$1.36M | ﹤0.01% | 1480 |
|
|
2021
Q2 | $2.01M | Buy |
14,838
+12,069
| +436% | +$1.59M | ﹤0.01% | 887 |
|
|
2021
Q1 | $375K | Buy |
2,769
+73
| +3% | +$10.9K | ﹤0.01% | 1639 |
|
|
2020
Q4 | $379K | Hold |
2,696
| – | – | ﹤0.01% | 1584 |
|
|
2020
Q3 | $300K | Sell |
2,696
-55
| -2% | -$6.17K | ﹤0.01% | 1591 |
|
|
2020
Q2 | $308K | Buy |
2,751
+600
| +28% | +$59.1K | ﹤0.01% | 1550 |
|
|
2020
Q1 | $167K | Sell |
2,151
-1,112
| -34% | -$98.5K | ﹤0.01% | 1756 |
|
|
2019
Q4 | $310K | Buy |
3,263
+1,653
| +103% | +$143K | ﹤0.01% | 1611 |
|
|
2019
Q3 | $123K | Buy |
1,610
+978
| +155% | +$81.3K | ﹤0.01% | 2051 |
|
|
2019
Q2 | $55K | Hold |
632
| – | – | ﹤0.01% | 2485 |
|
|
2019
Q1 | $57K | Hold |
632
| – | – | ﹤0.01% | 2440 |
|
|
2018
Q4 | $45K | Hold |
632
| – | – | ﹤0.01% | 2501 |
|
|
2018
Q3 | $61K | Hold |
632
| – | – | ﹤0.01% | 2463 |
|
|
2018
Q2 | $60K | Sell |
632
-1,236
| -66% | -$114K | ﹤0.01% | 2488 |
|
|
2018
Q1 | $164K | Buy |
1,868
+727
| +64% | +$66.4K | ﹤0.01% | 1988 |
|
|
2017
Q4 | $97K | Buy |
1,141
+138
| +14% | +$11.6K | ﹤0.01% | 2277 |
|
|
2017
Q3 | $87K | Buy |
1,003
+174
| +21% | +$13.9K | ﹤0.01% | 2311 |
|
|
2017
Q2 | $64K | Hold |
829
| – | – | ﹤0.01% | 2423 |
|
|
2017
Q1 | $58K | Sell |
829
-150
| -15% | -$10.1K | ﹤0.01% | 2415 |
|
|
2016
Q4 | $58K | Sell |
979
-1
| -0.1% | -$62 | ﹤0.01% | 2368 |
|
|
2016
Q3 | $65K | Buy |
980
+165
| +20% | +$10.2K | ﹤0.01% | 2303 |
|
|
2016
Q2 | $44K | Sell |
815
-555
| -41% | -$30.4K | ﹤0.01% | 2477 |
|
|
2016
Q1 | $71K | Buy |
1,370
+59
| +5% | +$3.06K | ﹤0.01% | 2201 |
|
|
2015
Q4 | $92K | Sell |
1,311
-1,335
| -50% | -$91.1K | ﹤0.01% | 2123 |
|
|
2015
Q3 | $164K | Sell |
2,646
-3
| -0.1% | -$236 | ﹤0.01% | 1809 |
|
|
2015
Q2 | $222K | Buy |
2,649
+255
| +11% | +$19.8K | ﹤0.01% | 1729 |
|
|
2015
Q1 | $180K | Buy |
2,394
+669
| +39% | +$46.7K | ﹤0.01% | 1840 |
|
|
2014
Q4 | $107K | Hold |
1,725
| – | – | ﹤0.01% | 2099 |
|
|
2014
Q3 | $90K | Sell |
1,725
-3
| -0.2% | -$153 | ﹤0.01% | 2164 |
|
|
2014
Q2 | $89K | Sell |
1,728
-3
| -0.2% | -$135 | ﹤0.01% | 2193 |
|
|
2014
Q1 | $82K | Buy |
1,731
+921
| +114% | +$47.1K | ﹤0.01% | 2236 |
|
|
2013
Q4 | $35K | Sell |
810
-39
| -5% | -$1.61K | ﹤0.01% | 2572 |
|
|
2013
Q3 | $37K | Buy |
849
+249
| +42% | +$10.1K | ﹤0.01% | 2457 |
|
|
2013
Q2 | $21K | Buy |
+600
| New | +$21.1K | ﹤0.01% | 2639 |
|
Other funds holding XBI
JFG
US Bancorp's XBI Position: Q2 2026 in Review
US Bancorp increased its State Street SPDR S&P Biotech ETF (XBI) stake by 88% in Q2 2026, buying an estimated $378K and bringing the position to 5,986 shares worth $947K. The position accounts for ﹤0.01% of the portfolio, ranked #1224.
US Bancorp first reported a position in XBI in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.57M in Q4 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- US Bancorp held 5,986 shares of State Street SPDR S&P Biotech ETF worth $947K as of Q2 2026.
- US Bancorp bought 2,798 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $378K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1224 holding.
- US Bancorp first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 53 quarters since.
- US Bancorp's State Street SPDR S&P Biotech ETF position peaked at $2.57M in Q4 2022.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.